Globally the demand for weight-loss drugs, specifically the glucagon-like peptide-1 (GLP-1) class of medications is ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Elixir Insurance Co. describes itself as a Medicare Part D prescription provider, which partners with national health care companies to provide medications. #NewsismyBusiness ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

South Carolina’s death chamber has a backlog because of a 13-year pause in executions in part because the state couldn’t ...

Sun Pharmaceutical Industries Ltd. 524715 shares slid 1.14% to ... MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top ...

Both drugs are JAK 1/2 inhibitors ... of the compound – a modification used to improve pharmacokinetic properties – that are infringed by Sun Pharma's compound. Ruxolitinib itself has shown ...

New rules require drugmakers to be clearer about explaining the risks and side effects of prescription drugs. The new ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Dilip Shanghvi's journey from the beginning with just Rs 2,000 highlights the importance of resilience, adaptability, and ...